Cross Country Healthcare (CCRN) Tops Q2 EPS by 5c, Offers Guidance

Cross Country Healthcare (NASDAQ: CCRN) reported Q2 EPS of $1.40, $0.05 better than the analyst estimate of $1.35. Revenue for the quarter came in at $753.6 million versus the consensus estimate of $740.94 million.

GUIDANCE:

Cross Country Healthcare sees Q3 2022 EPS of $0.85-$0.95, versus the consensus of $0.91. Cross Country Healthcare sees Q3 2022 revenue of $605-615 million, versus the consensus of $587.1 million.

For earnings history and earnings-related data on Cross Country Healthcare (CCRN) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• Green Dot and CommerceOne shareholders approve acquisition deal